menu search

Why shares of bioxcel therapeutics fell this week

The company has one marketed treatment -- Igalmi, which reduces agitation in patients with bipolar diso...

September 28, 2023, 5:35 pm

A bipolar world of stock market performances

US benchmark stock indices continue to maintain global leadership as its cyclical laggards are now playing catch up to the technology-related Magnific...

July 19, 2023, 7:53 am

A bipolar world of stock market performances

US benchmark stock indices continue to maintain global leadership as its cyclical laggards are now playing catch up to the technology-related Magnific...

July 19, 2023, 7:22 am

Welcome to a bipolar world of monetary policies

Monetary policies and guidance of the 4 major central banks are moving in the opposite direction. US Fed and Eurozone ECB are in the hawkish camp whil...

June 16, 2023, 7:19 am

Ballard (bldp) to increase bipolar plates production, cut costs

Ballard Power System (BLDP) announces increasing production volumes of its proprietary graphite bipolar...

June 13, 2023, 1:33 pm

Teleflex's (tfx) wattson temporary pacing receives fda nod

Teleflex's (TFX) Wattson Temporary Pacing Guidewire offers dual functionality, allowing both valve delivery and ventricular ...

June 8, 2023, 1:53 pm

Teleflex receives fda clearance for the wattson® temporary pacing guidewire

Company expands Structural Heart Portfolio with the first commercially available bipolar temporary paci...

June 7, 2023, 10:30 am

Intra-cellular therapies: depression data boosts investment prospects (rating upgrade)

Intra-Cellular's drug Caplyta (lumateperone) is advancing through trials for major depressive disorder (MDD), expanding its approved uses beyond schiz...

May 25, 2023, 7:51 pm

Why shares of bioxcel therapeutics are dropping thursday

BioXcel Therapeutics got approval last year for Igalmi to treat acute agitation in adults with schizophrenia or ...

May 25, 2023, 12:40 pm

Bioxcel stock crashes 22% as bid to double its market appears less certain

Shares of BTAI stock plummeted after BioXcel's Igalmi missed the mark in patients with agitation due to schizophrenia or ...

May 25, 2023, 12:04 pm

Antipsychotic drugs market size to hit usd 33.5 billion by 2030 at 5.70% cagr – report by market research future (mrfr)

Antipsychotic Drugs Market Trends and Insights By Generation (First Generation, Second Generation), By Type (Atypical Antipsychotic, Miscellaneous Ant...

May 23, 2023, 5:30 pm

Insulated gate bipolar transistor (igbt) market is estimated to cross us$ 14.9 billion at a cagr of 8.3% during forecast period 2023 to 2033 | future market insights, inc.

The market value of insulated gate bipolar transistors (IGBT) in the United Kingdom is predicted to inc...

May 9, 2023, 4:30 pm

Intra-cellular's stock jumps on new data for depression drug

Shares of Intra-Cellular Therapies Inc. ITCI, +2.46% jumped about 15% in premarket trading on Tuesday after the company said its experimental treatmen...

March 28, 2023, 8:16 am

Ideal power releases whitepaper on b-tran™: compelling advantages over conventional power switch technologies

AUSTIN, Texas, Feb. 28, 2023 (GLOBE NEWSWIRE) — Ideal Power Inc. (Nasdaq: IPWR), pioneering the development and commercialization of the highly effi...

February 28, 2023, 9:49 pm

Nrx pharmaceuticals to present scientific update at the 6th annual sachs associates neuroscience innovation forum in conjunction with the 2023 j.p. morgan healthcare conference

RADNOR, Pa. , Jan. 5, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharma...

January 5, 2023, 6:47 am

Intra-cellular: hitting a growth inflection (rating upgrade)

Following approval for schizophrenia in late 2019, Caplyta then gained its first label expansion for bipolar...

December 18, 2022, 9:30 am

Intra-cellular's (itci) caplyta aids growth, overdependence a woe

Intra-Cellular Therapeutics (ITCI) currently has only one marketed product in its portfolio, Caplyta, approved for schizophrenia and ...

November 18, 2022, 3:11 pm

'losing my mind': bonobos founder who helped transform walmart opens up about mental health struggles

Andy Dunn, co-founder of Walmart-acquired Bonobos, opens up in his new book about struggling to manage his bip...

June 11, 2022, 7:00 am

Why bioxcel therapeutics stock is surging today

BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading higher Wednesday after the company announced that the U.S. Food and Drug Administration app...

April 6, 2022, 9:22 am

Bioxcel says the fda approved its therapy for adults with schizophrenia or bipolar disorder

Shares of BioXcel Therapeutics Inc. BTAI, -2.98% jumped 14.6% in premarket trading on Wednesday after the company said the Food and Drug Administratio...

April 6, 2022, 8:02 am


Search within

Pages Search Results: